CLASS II Drug recall · Reported 8 Jan 2025 · FDA Enforcement Report

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg) recalled

Lupin Pharmaceuticals is recalling Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), distributed in Ohio. The recall was initiated on 20 Dec 2024 and the FDA has classified it as Class II.

Check your package

Lot, batch or date codesLot# LA01276, Exp Date: 07/2026
NDC68180-965, 68180-966, 68180-967, 68180-968, 68180-969, 68180-970
UPC0368180973010, 0368180971016, 0368180972013, 0368180969013, 0368180966012, 0368180970019
Quantity recalled480 1000-count bottles

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

Recall details

Recall number
D-0167-2025
FDA event ID
95892
Recalling firm
Lupin Pharmaceuticals, Baltimore, MD
Manufacturer
Lupin Pharmaceuticals, Inc.
Classification
Class II
Status
Terminated
Recall initiated
20 Dec 2024
FDA classified
30 Dec 2024
Reported
8 Jan 2025
Type
Voluntary: Firm initiated
Customers notified by
E-Mail
Reason category
Potency & Assay

Timeline

20 Dec 2024Recall initiated by company
30 Dec 2024Classified by FDA+10 days
8 Jan 2025Published in enforcement report+9 days

Companies usually start a recall weeks before the FDA classifies and publishes it; the gap above is that lag.

Reason for recall

Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Potency and specification recalls happen when a batch tests outside its approved limits for strength, purity or dissolution, which can mean the dose delivered is higher or lower than labelled.

Product as listed by the FDA

Levothyroxine Sodium Tablets, Lupin, 75 mcg (0.075mg), 1000 Tablets, Rx Only, Manufactured for: Lupin Pharmaceuticals, Inc. Baltimore, Maryland 21202 United States, Manufactured by: Lupin Limited, Pithampur (M.P)- 454 775 INDIA, NDC# 68180-967-03

Where it was distributed

One US distributor in Ohio.

Ohio

Questions about this recall

Why was it recalled?

Failed Impurities/Degradation Specifications: Out of specifications result observed in the drug substance for impurity test during 3-month long term stability study.

Which lots are affected?

Lot# LA01276, Exp Date: 07/2026

Where was it sold?

One US distributor in Ohio.

What should I do if I have it?

Check the lot number on your package against the affected lots. If it matches, contact the pharmacy that dispensed it or your prescriber before stopping any medication.

What does Class II mean?

Class II means the product may cause temporary or medically reversible health problems, or the probability of serious harm is remote.

Read the official FDA notice · Source record retrieved 26 Sep 2026. The FDA describes openFDA data as unvalidated; the official notice takes precedence. This page reports the record and gives no medical advice.

More recalls from Lupin Pharmaceuticals

All 123

Other Levothyroxine recalls

All 137